Impaired sensitivity in non-responders to pegylated interferon plus ribavirin therapy assessed by 2′-5′-oligoadenylate synthetase activity

被引：0
|
作者：
Shindo, Michiko
Hamada, Kazushige
Morikawa, Teruhisa
Harano, Yuichi
Nakajima, Tomoaki
Okuno, Tadao
机构：
[1] Akashi Municipal Hosp, Akashi, Hyogo, Japan
[2] Kyoto Inst Technol, Kyoto 606, Japan
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
333
引用
收藏
页码：388A / 388A
页数：1
相关论文
共 50 条
  • [21] Interferon plus ribavirin re-treatment in hemophilic patients relapsers or non-responders to interferon alone.
    Rumi, M
    Santagostino, E
    Soffredini, R
    Rivi, M
    Gringeri, A
    Colombo, M
    Mannucci, PM
    HEPATOLOGY, 2000, 32 (04) : 557A - 557A
  • [22] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy
    Chousterman, N
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
  • [23] Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience
    Brillanti, S
    Miglioli, M
    Barbara, L
    JOURNAL OF HEPATOLOGY, 1995, 23 : 13 - 16
  • [24] EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL
    Hezode, C.
    Foucher, J.
    Bronowicki, J. -P.
    Leroy, V.
    Tran, A.
    Larrey, D.
    Mathurin, P.
    Rosa, I.
    Alric, L.
    Dhalluin-Venier, V.
    Nani, A.
    Bouvier-Alias, M.
    Rouanet, S.
    Couzigou, P.
    Mallat, A.
    Charaf-Eddine, M.
    Pawlotsky, J. -M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S50 - S50
  • [25] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [26] A phase 2 study of albuferon in combination with ribavirin in non-responders to prior interferon therapy for chronic hepatitis C
    Nelson, D
    Rustgi, V
    Balan, V
    McHutchison, J
    Davis, G
    Lambiase, L
    Sulkowski, M
    Dickson, R
    Fiscella, M
    Yu, R
    Davidson, H
    Cronin, P
    Freimuth, W
    Subramanian, M
    HEPATOLOGY, 2005, 42 (04) : 278A - 278A
  • [27] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [28] Comparison of Pegylated interferon plus ribavirin with or without induction therapy for the treatment of chronic hepatitis C (HCV) non-responders.
    Bzowej, N
    Gish, R
    Wakil, A
    Brooks, L
    Shaffer, M
    Leung, J
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [29] EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN (RBV) IN HCV GENOTYPE 1 NON-RESPONDERS: FINAL RESULTS OF THE SYREN TRIAL
    Hezode, Christophe
    Foucher, Juliette
    Bronowicki, Jean-Pierre
    Leroy, Vincent
    Tran, Albert
    Larrey, Dominique
    Mathurin, Philippe
    Rosa, Isabelle
    Alric, Laurent
    Barrault, Camille
    Nani, Abdelbasset
    Bouvier-Alias, Magali
    Rouanet, Stephanie
    Couzigou, Patrice
    Mallat, Ariane
    Eddine, Mariem Charaf
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2010, 52 (04) : 718A - 718A
  • [30] COMPARISON OF ROLLOVER VS WASHOUT DAILY INTERFERON ALFACON-1 AND RIBAVIRIN IN THE RETREATMENT OF NON-RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN FOR HEPATITIS C VIRUS INFECTION
    Fahmy, Marianne
    Gabbert, Charles
    Richards, Lisa
    Andrews, Barbara G.
    Kuo, Alexander
    HEPATOLOGY, 2010, 52 (04) : 814A - 815A
12345